Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
19,105,701
Share change
+641,811
Total reported value
$787,305,601
Put/Call ratio
63%
Price per share
$41.39
Number of holders
165
Value change
+$28,307,048
Number of buys
66
Number of sells
77

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2022

As of 31 Mar 2022, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 165 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,105,701 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Fairmount Funds Management LLC, Bellevue Group AG, Avidity Partners Management LP, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., and BAKER BROS. ADVISORS LP. This page lists 165 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.